# Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple Sclerosis

> **NCT02904876** · PHASE4 · TERMINATED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 70 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **RADIATION:** Diffusion Magnetic Resonance Imaging at 6 months

## Key facts

- **NCT ID:** NCT02904876
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2019-12
- **Final completion:** 2020-05
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02904876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02904876, "Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02904876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*